Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Experts call the health implications “dire” with some fearing Kennedy could set off a fresh round in the school culture wars ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

Following a low-oxalate diet means cutting vegetables and fruits high in oxalates and eating calcium-rich foods. This food ...

No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

Labonte, 41, went home to be with her Lord and Savior after a 41-year courageous ... AUGUSTA – Amanda Jeanette Lorraine ...

After Vertex President and CEO Reshma Kewalramani presented at the firm’s healthcare conference, JPMorgan analyst Jessica Fye notes that the ...

J.P. Morgan analyst Jessica Fye has maintained their bullish stance on VRTX stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...

The company will prioritize its cash in funding its ongoing Phase 1/2 PRISM clinical trial and Phase 3 4FRONT program.

Explore the courageous journey of Claire Wineland as she shared her life with cystic fibrosis, inspiring many.